Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. - Wikidata - awgldk - TriplyDB

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

http://www.wikidata.org/entity/Q34722281

about

Proteomic profile of dormant Trichophyton rubrum conidia Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus Terbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulans.Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags.Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum.Agar-based disk diffusion assay for susceptibility testing of dermatophytes.A foot in the door for dermatophyte research.Identification of the Trichophyton mentagrophytes complex species using MALDI-TOF mass spectrometry.Photodynamic and Nail Penetration Enhancing Effects of Novel Multifunctional Photosensitizers Designed for The Treatment of Onychomycosis.Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.Fast and accurate identification of dermatophytes by matrix-assisted laser desorption ionization-time of flight mass spectrometry: validation in the clinical laboratory.New pharmacotherapy for the treatment of onychomycosis: an update.Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes In vitro activities of miltefosine and two novel antifungal biscationic salts against a panel of 77 dermatophytes.The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive?Emerging therapeutic agents for onychomycosis.Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study Terbinafine: a pharmacological and clinical review.Dermatophytes: host-pathogen interaction and antifungal resistance.An update on treatment of onychomycosis.Anti dermatophytic therapy--prospects for the discovery of new drugs from natural products.Onychomycosis nailed.Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections.The first succinylome profile of Trichophyton rubrum reveals lysine succinylation on proteins involved in various key cellular processes.Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns.Antidermatophytic and Protease-inhibiting Activities of Zerumbone: A Natural Sesquiterpene from the Rhizome of Zingiber zerumbet (L.) Roscoe ex J.E; Smith.Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.Improving Cure Rates in Onychomycosis.In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.Topical Treatment of Dermatophytic Lesion on Mice (Mus musculus) Model.Synthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum.Treatment of dermatophytosis by a new antifungal agent 'apigenin'.In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis.In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine.Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene.

P2860

Q21263181-65543744-E4D3-4E59-AC37-3C0AFC8DB496 Q27939054-5D34902F-9C5D-455F-9320-F1DD6D529814 Q30764085-F6750252-997C-4F83-8C63-CD0C6365CD55 Q31108109-CECC4535-B8B6-4B3E-B5DB-5CCA17FCC102 Q33259999-59502466-A73E-4219-99EC-86883E6A9950 Q33261315-24650D97-EE93-4C7C-9609-279A0D354FFD Q33753320-6230084A-18C3-489C-8678-630DF66BA54D Q33797831-44A01924-85EB-4D7E-A5B3-9CB2C2CED9A0 Q34190254-00557C4D-FD00-4158-AE9C-F5CEB99EB7D9 Q34220943-4C448AEA-B0A8-4B1F-A55C-697141270525 Q34626439-1C8773FE-9DD8-4F79-A26E-7DD80A4A9BA2 Q35028909-7811E143-1031-4310-B31C-E29C147E2AA7 Q35182564-FAAC4B20-3BDE-4F7D-97B5-DDF9ABD7EAF4 Q35207944-A56EB3E3-6EAA-4390-9DDA-99D9D262A513 Q35530025-51801526-E7DD-49D8-A99E-B6532008957F Q35713867-3F5D1D06-412D-4811-BF82-0B34205BC345 Q35840802-4E0C2B8B-97CB-4512-B646-3444192E35A1 Q36720502-0DB7C0C5-2FDD-4EAC-9A66-E4506ECBB4FE Q36943999-9D2F45EE-9D6F-47EC-9621-EC9290F4C095 Q37268303-31B1E8BD-7422-4879-915C-FDA8A3F16248 Q37623829-19AA8EF8-5447-4C5D-B461-16CE08256098 Q37820280-D6BE08EB-EC17-4C1C-86D2-CC262CA57DE9 Q38006059-9C5E8191-F140-4738-9491-90854E7F5EAF Q38201012-7F2CDEC0-F9E0-4CDA-A112-32EE224E689B Q38326477-1C6515EB-9483-4C38-9F51-B9E80C1ACBC7 Q38395485-43FED5E0-0D2F-4FB7-B19A-88DFA1278478 Q38640400-3798836A-400F-46F2-9241-21F3E29714AC Q38693024-1C246F46-673C-4AA3-8DC4-F26FC9B3BC4E Q38715709-9EBD34EA-83C0-4F32-9369-135406AB9605 Q38848739-EF5889E5-867B-43C6-9C01-6018D61FDAED Q38867934-07F9150A-FBD2-438F-A11C-DC5A1BD5B7B7 Q38878593-047644D7-269E-4F3F-B855-A594E1E2B537 Q38887854-D92FF70A-FA8C-4FE4-AD57-932E0FBE5070 Q38969400-311D713B-4CC4-497B-92F7-59F6B29B1913 Q39126938-DAA929CC-2848-439F-942D-D94A45CCDE0A Q39214505-0AF50776-5128-4852-90D9-E4668F1FB959 Q39220841-5EA42A15-C997-4756-B8B8-24A3110562F6 Q40099588-80BE0F82-4B33-4E15-B246-B9D57BC062DE Q40130565-D43970FE-5AAF-488B-85FC-EE1D8D2720A2 Q40248068-8FC9BA14-FE60-423A-9BE1-F29B97A4C8E5

P2860

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

http://www.wikidata.org/entity/Q34722281

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@ast

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@en

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@nl

type

label

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@ast

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@en

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@nl

prefLabel

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@ast

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@en

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@nl

P1433

Q34722281-F8154D41-616A-45B7-89C5-CC93267EE3D4

P1476

Q34722281-5F8ABA1E-58FA-4B5E-99ED-E84C9D137AFD

P2093

Q34722281-0E10FA87-1039-4F43-ADCB-68941C54E26B

Q34722281-7A55487B-B589-4D4B-8621-E139FFE43545

Q34722281-81247E61-6753-4DE7-988A-2E9E6C3B4CD0

Q34722281-B2351F84-530D-43E1-B5FE-3EDD0C6B40A9

Q34722281-CA8139C1-D30D-4BA2-8D68-70A8D4E45BA0

Q34722281-D6E9E530-245E-4558-9753-2DFF227E7F41

P2860

Q34722281-021BC877-80FA-4504-BCF5-3640BFE41D98

Q34722281-1CEF45E7-355C-4C4B-BD61-C74F9C4C54B8

Q34722281-2180B01D-AFE8-46CE-99B6-B2946E261B94

Q34722281-29A48222-2ECC-4D0C-BA73-F0DF5917A2EC

Q34722281-347E7224-8EE4-4E66-BD4C-A467371625A2

Q34722281-421358F5-F515-43BE-B99E-F385EB8B9CA1

Q34722281-4F0F1F1D-A775-4B80-941A-8B3F3203AFE4

Q34722281-6A41D59B-3A39-487A-8A3A-D6CBBBB19903

Q34722281-79155592-913D-4383-A659-E52F9353D394

Q34722281-860292A8-1907-4557-8813-CA79F1F52412

P304

Q34722281-AFFF590B-F819-4CF0-945D-8C6A34A3C794

P31

Q34722281-48F7587B-5F84-484A-94F8-9159793B5CAE

P356

Q34722281-7AA09CDA-DDCC-4BF3-A1C0-F75186C209A2

P407

Q34722281-77DBD39A-6FD2-486C-A334-00F1C99E883C

P433

Q34722281-D9F65065-6EC6-43D4-8615-481AAFA17C5E

P478

Q34722281-84F02BDD-5950-4422-822D-1AD11F3B65B2

P577

Q34722281-FE34E0FE-F46C-4F67-8964-091774D54015

P5875

Q34722281-17FB1F69-EF24-484B-ACE8-56927178F4D7

P698

Q34722281-1919F5B1-0973-4888-8416-02FCCB7B1820

P921

Q34722281-895A3118-99C5-4BB2-BF44-BF209E3B4E95

P932

Q34722281-57072BEA-6F52-4324-BB70-11987B02B600

P356

AAC.47.1.82-86.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

@en

P2093

Ingrid Leitner

http://www.w3.org/2001/XMLSchema#string

Mahmoud A Ghannoum

http://www.w3.org/2001/XMLSchema#string

Nancy Isham

http://www.w3.org/2001/XMLSchema#string

Neil S Ryder

http://www.w3.org/2001/XMLSchema#string

Pranab K Mukherjee

http://www.w3.org/2001/XMLSchema#string

Steven D Leidich

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

The dermatophytes

An evaluation of the in vitro activity of terbinafine.

A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.

Antifungals: mechanism of action and resistance, established and novel drugs.

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions.

Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates.

Dermatophyte infections in human immune deficiency virus (HIV) disease.

P304

82-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.1.82-86.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10976441

http://www.w3.org/2001/XMLSchema#string

P698

12499173

http://www.w3.org/2001/XMLSchema#string

P921

P932

148991

http://www.w3.org/2001/XMLSchema#string